TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI)
CUSIP: 89680M101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 61,418,480
- Total 13F shares
- 9,563,230
- Share change
- +1,091,367
- Total reported value
- $44,470,060
- Price per share
- $4.65
- Number of holders
- 54
- Value change
- +$5,042,569
- Number of buys
- 27
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 89680M101?
CUSIP 89680M101 identifies TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89680M101:
Top shareholders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MedTech Acquisition Sponsor LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,250,000
mixed-class rows
|
$65,538,115 | — | 26 Jun 2023 | |
| Frankenius Equity AB |
13D/G
3/4/5
|
10%+ Owner |
14%
|
6,989,748
|
$34,179,868 | +$1,257,864 | 31 Jul 2025 | |
| Mats Wahlstrom |
13D/G
|
— |
6%
|
2,987,881
|
$14,610,738 | +$931,271 | 31 Jul 2025 | |
| Nantahala Capital Management, LLC |
13F
13D/G
|
Company |
4.1%
from 13D/G
|
2,000,000
|
$10,900,000 | — | 30 Jun 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
2%
|
1,250,000
|
$6,812,500 | — | 30 Jun 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.8%
|
1,092,975
|
$5,956,714 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
814,389
|
$4,438,419 | — | 30 Jun 2025 | |
| Sean Murphy |
3/4/5
|
Director |
—
mixed-class rows
|
1,308,937
mixed-class rows
|
$3,818,390 | — | 12 Jun 2025 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
1%
|
643,740
|
$3,508,383 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1%
|
621,689
|
$3,388,205 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.91%
|
557,500
|
$3,038,375 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
455,051
|
$2,480,299 | — | 30 Jun 2025 | |
| George Kelly Martin |
3/4/5
|
Director |
—
mixed-class rows
|
262,176
mixed-class rows
|
$1,359,468 | — | 28 Aug 2024 | |
| Graypoint LLC |
13F
|
Company |
—
class O/S missing
|
827,590
|
$1,075,867 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.31%
|
188,906
|
$1,029,537 | — | 30 Jun 2025 | |
| Arjun Jj Desai |
3/4/5
|
Director |
—
mixed-class rows
|
312,127
mixed-class rows
|
$911,899 | — | 12 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
126,263
|
$688,134 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.19%
|
115,597
|
$630,004 | — | 30 Jun 2025 | |
| James Alecxih |
3/4/5
|
President, Device Technology |
—
class O/S missing
|
94,754
|
$521,147 | — | 10 Aug 2023 | |
| James Emmett Young |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
154,663
mixed-class rows
|
$428,854 | — | 19 May 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
75,400
|
$410,930 | — | 30 Jun 2025 | |
| Steven C. Katz |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
173,587
mixed-class rows
|
$377,229 | — | 12 Feb 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
56,328
|
$306,987 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
50,012
|
$272,565 | — | 30 Jun 2025 | |
| Vestcor Inc |
13F
|
Company |
—
mixed-class rows
|
94,208
mixed-class rows
|
$229,000 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
41,801
|
$227,814 | — | 30 Jun 2025 | |
| MSD Partners, L.P. |
13F
|
Company |
0.07%
|
39,999
|
$217,995 | — | 30 Jun 2025 | |
| Connective Capital Management, LLC |
13F
|
Company |
0.05%
|
32,796
|
$178,738 | — | 30 Jun 2025 | |
| Magnetar Financial LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
16,668
|
$174,782 | — | 12 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
30,253
|
$164,879 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
29,937
|
$163,157 | — | 30 Jun 2025 | |
| Connecticut Wealth Management, LLC |
13F
|
Company |
0.04%
|
22,303
|
$121,551 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.03%
|
20,594
|
$112,237 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
20,558
|
$112,041 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
19,800
|
$107,910 | — | 30 Jun 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
19,454
|
$106,000 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
19,288
|
$105,120 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
16,816
|
$91,647 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
16,692
|
$90,971 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
16,463
|
$89,717 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
10,775
|
$58,723 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
8,705
|
$47,442 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
7,540
|
$41,093 | — | 30 Jun 2025 | |
| Liselotte Hyveled |
3/4/5
|
Director |
—
mixed-class rows
|
60,040
mixed-class rows
|
$39,859 | — | 02 Jan 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
23,540
|
$30,367 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
5,427
|
$29,577 | — | 30 Jun 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.01%
|
5,400
|
$29,430 | — | 30 Jun 2025 | |
| B & T Capital Management DBA Alpha Capital Management |
13F
|
Company |
—
class O/S missing
|
22,222
|
$28,889 | — | 30 Jun 2025 | |
| Arax Advisory Partners |
13F
|
Company |
0.01%
|
4,008
|
$21,844 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3,015
|
$16,432 | — | 30 Jun 2025 |
Institutional Holders of TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) as of Q3 2025
As of 30 Sep 2025,
TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,563,230 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, GILDER GAGNON HOWE & CO LLC, BlackRock, Inc., Wealthcare Advisory Partners LLC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and BANK OF AMERICA CORP /DE/.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
46
Q3 2025 holders
54
Holder diff
8
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.